{
    "Trade/Device Name(s)": [
        "Healgen Amphetamine Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen Oxycodone Test (Strip, Cassette, Cup, Dip Card)"
    ],
    "Submitter Information": "HEALGEN SCIENTIFIC LLC",
    "510(k) Number": "K143187",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DJG"
    ],
    "Summary Letter Date": "October 31, 2014",
    "Summary Letter Received Date": "November 5, 2014",
    "Submission Date": "January 21, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay"
    ],
    "Methodologies": [
        "Competitive binding",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Cup",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen Amphetamine and Oxycodone Tests, lateral flow immunochromatographic urine drug screening assays in strip, cassette, dip card, and cup formats",
    "Indications for Use Summary": "Qualitative, preliminary determination of amphetamine (cutoff 1000 ng/mL) and oxycodone (cutoff 100 ng/mL) in human urine for in vitro diagnostic use, available OTC and by prescription, results should be confirmed by alternative chemical methods",
    "fda_folder": "Toxicology"
}